The Medicines Company Seeks To Sharpen Angiomax Label With ACUITY Data
This article was originally published in The Pink Sheet Daily
Executive Summary
An acute coronary syndromes claim based on ACUITY would open up nearly 2 million additional potential patients per year for the anticoagulant, COO Kelley tells “The Pink Sheet” DAILY.